Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.

Wring SA, Randolph R, Park S, Abruzzo G, Chen Q, Flattery A, Garrett G, Peel M, Outcalt R, Powell K, Trucksis M, Angulo D, Borroto-Esoda K.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02068-16. doi: 10.1128/AAC.02068-16. Print 2017 Apr.

2.

Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: model prediction and clinical confirmation.

Stroh M, Talaty J, Sandhu P, McCrea J, Patnaik A, Tolcher A, Palcza J, Orford K, Breidinger S, Narasimhan N, Panebianco D, Lush R, Papadopoulos KP, Wagner JA, Trucksis M, Agrawal N.

J Clin Pharmacol. 2014 Nov;54(11):1256-62. doi: 10.1002/jcph.331. Epub 2014 May 24.

PMID:
24827931
3.

A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer.

Lush RM, Patnaik A, Sullivan D, Papadopoulos KP, Trucksis M, McCrea J, Cerchio K, Li X, Stroh M, Selverian D, Orford K, Ebbinghaus S, Agrawal N, Iwamoto M, Wagner JA, Tolcher A.

Cancer Chemother Pharmacol. 2012 Oct;70(4):567-74. Epub 2012 Aug 10.

4.

The minimal impact of food on the pharmacokinetics of ridaforolimus.

Stroh M, Li X, Marsilio S, Panebianco D, Johnson-Levonas A, Juan A, Orford K, Agrawal N, Trucksis M, Wagner JA, Murphy G, Iwamoto M.

Cancer Chemother Pharmacol. 2012 Jul;70(1):177-82. doi: 10.1007/s00280-012-1897-8. Epub 2012 Jun 6.

PMID:
22669570
5.

UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study.

Wang YH, Trucksis M, McElwee JJ, Wong PH, Maciolek C, Thompson CD, Prueksaritanont T, Garrett GC, Declercq R, Vets E, Willson KJ, Smith RC, Klappenbach JA, Opiteck GJ, Tsou JA, Gibson C, Laethem T, Panorchan P, Iwamoto M, Shaw PM, Wagner JA, Harrelson JC.

Clin Pharmacol Ther. 2012 Jul;92(1):96-102. doi: 10.1038/clpt.2012.20. Epub 2012 Jun 6.

6.

The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.

Stroh M, Palcza J, McCrea J, Marsilio S, Breidinger S, Panebianco D, Johnson-Levonas A, Kraft WK, Orford K, Murphy G, Agrawal N, Trucksis M, Wagner JA, Iwamoto M.

Cancer Chemother Pharmacol. 2012 May;69(5):1247-53. doi: 10.1007/s00280-011-1819-1.

PMID:
22290273
7.

The American cotton rat: a novel model for pulmonary tuberculosis.

Elwood RL, Wilson S, Blanco JC, Yim K, Pletneva L, Nikonenko B, Samala R, Joshi S, Hemming VG, Trucksis M.

Tuberculosis (Edinb). 2007 Mar;87(2):145-54. Epub 2006 Sep 12.

PMID:
16973421
8.

Chronic Q fever in the United States.

Karakousis PC, Trucksis M, Dumler JS.

J Clin Microbiol. 2006 Jun;44(6):2283-7. Review.

9.

Molecular and physiological effects of mycobacterial oxyR inactivation.

Pagán-Ramos E, Master SS, Pritchett CL, Reimschuessel R, Trucksis M, Timmins GS, Deretic V.

J Bacteriol. 2006 Apr;188(7):2674-80.

10.

Identification of Mycobacterium marinum virulence genes using signature-tagged mutagenesis and the goldfish model of mycobacterial pathogenesis.

Ruley KM, Ansede JH, Pritchett CL, Talaat AM, Reimschuessel R, Trucksis M.

FEMS Microbiol Lett. 2004 Mar 12;232(1):75-81.

11.

Goldfish as an animal model system for mycobacterial infection.

Ruley KM, Reimschuessel R, Trucksis M.

Methods Enzymol. 2002;358:29-39. No abstract available.

PMID:
12474377
12.

Vibrio cholerae ACE stimulates Ca(2+)-dependent Cl(-)/HCO(3)(-) secretion in T84 cells in vitro.

Trucksis M, Conn TL, Wasserman SS, Sears CL.

Am J Physiol Cell Physiol. 2000 Sep;279(3):C567-77.

13.

Transformation and transposition of the genome of Mycobacterium marinum.

Talaat AM, Trucksis M.

Am J Vet Res. 2000 Feb;61(2):125-8.

PMID:
10685681
14.
15.

Pathogenicity of Mycobacterium fortuitum and Mycobacterium smegmatis to goldfish, Carassius auratus.

Talaat AM, Trucksis M, Kane AS, Reimschuessel R.

Vet Microbiol. 1999 Apr 1;66(2):151-64.

PMID:
10227476
16.
17.

The Vibrio cholerae genome contains two unique circular chromosomes.

Trucksis M, Michalski J, Deng YK, Kaper JB.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14464-9.

18.

Goldfish, Carassius auratus, a novel animal model for the study of Mycobacterium marinum pathogenesis.

Talaat AM, Reimschuessel R, Wasserman SS, Trucksis M.

Infect Immun. 1998 Jun;66(6):2938-42.

19.
20.

Production of Vibrio cholerae accessory cholera enterotoxin (Ace) in the yeast Pichia pastoris.

Trucksis M, Conn TL, Fasano A, Kaper JB.

Infect Immun. 1997 Dec;65(12):4984-8.

21.

Disseminated cutaneous zoster and aseptic meningitis in a previously healthy patient.

Moriuchi H, Moriuchi M, Sun CC, Trucksis M.

J Infect. 1997 Sep;35(2):183-5.

PMID:
9354356
22.

Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene.

Franco AA, Mundy LM, Trucksis M, Wu S, Kaper JB, Sears CL.

Infect Immun. 1997 Mar;65(3):1007-13.

25.

Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette.

Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB.

Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5267-71.

26.

A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus.

Trucksis M, Wolfson JS, Hooper DC.

J Bacteriol. 1991 Sep;173(18):5854-60.

27.

Emerging resistance to fluoroquinolones in staphylococci: an alert.

Trucksis M, Hooper DC, Wolfson JS.

Ann Intern Med. 1991 Mar 1;114(5):424-6. No abstract available.

PMID:
1992885
28.

Bronchiectasis: a current view.

Trucksis M, Swartz MN.

Curr Clin Top Infect Dis. 1991;11:170-205. Review. No abstract available.

PMID:
1867766
29.

Escherichia coli and Salmonella typhimurium supX genes specify deoxyribonucleic acid topoisomerase I.

Trucksis M, Golub EI, Zabel DJ, Depew RE.

J Bacteriol. 1981 Aug;147(2):679-81.

30.

Supplemental Content

Loading ...
Support Center